|
Volumn 11, Issue 2, 2015, Pages 237-241
|
Evolution of the NBOMes: 25C- and 25B- Sold as 25I-NBOMe
|
Author keywords
Drugs of abuse; NBOMe; New psychoactive substances; Serotonin toxicity; Substituted phenylethylamines
|
Indexed keywords
25B-NBOME;
25C-NBOME;
BENZODIAZEPINE;
BICARBONATE;
CREATINE KINASE;
LACTIC ACID;
LORAZEPAM;
N BENZYL OXY METHYL DERIVATIVE;
PSYCHEDELIC AGENT;
SODIUM;
UNCLASSIFIED DRUG;
2-(4-BROMO-2,5-DIMETHOXYPHENYL)-N-((2-METHOXYPHENYL)METHYL)ETHANAMINE;
2-(4-IODO-2,5-DIMETHOXYPHENYL)-N-(2-METHOXYBENZYL)ETHANAMINE;
ANISOLE DERIVATIVE;
BENZODIAZEPINE DERIVATIVE;
CENTRAL STIMULANT AGENT;
DESIGNER DRUG;
HOMOVERATRYLAMINE;
HYPNOTIC SEDATIVE AGENT;
PHENETHYLAMINE DERIVATIVE;
SEROTONIN 2 AGONIST;
SEROTONIN 2A RECEPTOR;
ADOLESCENT;
ARTICLE;
BEHAVIOR DISORDER;
CASE REPORT;
DRUG INTOXICATION;
ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE;
FEMALE;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
LEUKOCYTE COUNT;
MALE;
MASS SPECTROMETRY;
MENTAL HEALTH;
MUSCLE RIGIDITY;
SEIZURE;
SOLID PHASE EXTRACTION;
TANDEM MASS SPECTROMETRY;
TONIC CLONIC SEIZURE;
TOXICOLOGY;
URINALYSIS;
ANALOGS AND DERIVATIVES;
BLOOD;
CHEMICALLY INDUCED;
CHEMISTRY;
DRUG DEPENDENCE;
DRUG EFFECTS;
MENTAL DISEASE;
PSYCHOLOGY;
SEIZURES;
ADOLESCENT;
ANISOLES;
BENZODIAZEPINES;
CENTRAL NERVOUS SYSTEM STIMULANTS;
CREATINE KINASE;
DESIGNER DRUGS;
DIMETHOXYPHENYLETHYLAMINE;
FEMALE;
HUMANS;
HYPNOTICS AND SEDATIVES;
MALE;
MASS SPECTROMETRY;
MENTAL DISORDERS;
MUSCLE RIGIDITY;
PHENETHYLAMINES;
RECEPTOR, SEROTONIN, 5-HT2A;
SEIZURES;
SEROTONIN 5-HT2 RECEPTOR AGONISTS;
SUBSTANCE-RELATED DISORDERS;
|
EID: 84931569369
PISSN: 15569039
EISSN: 19376995
Source Type: Journal
DOI: 10.1007/s13181-014-0445-9 Document Type: Article |
Times cited : (32)
|
References (10)
|